Objectives: This single-institution study evaluates the feasibility of accelerated fractionation radiotherapy (AF) with and without mitomycin C (MMC) in the treatment of locally advanced head and neck cancer. Patients and Methods: Between May 1998 and Oc-tober 2001, sixty patients with locally advanced stage III and IV of head and neck cancer were randomized into three treatment arms: (1) conventional fractionation radio-therapy (CF) (5 fractions per week); (2) accelerated fractionation radiotherapy (AF) (6 fractions per week); and (3) AF plus Mitomycin C (MMC). Results: The 2-year overall survival (OS) of the whole group was 21%. The OS according to treatment arm was 23%, 20%, and 28 % in CF, AF, and AF+MMC arm
BACKGROUND: The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) s...
Aim: To determine the maximum tolerated dose (MTD) of a short-course accelerated radiotherapy and it...
Purpose: To compare the benefit achieved by concurrent chemoradiotherapy (CRT) and/or accelerated fr...
Purpose: To evaluate the effect of mitomycin C to an accelerated hyperfractionated radiation therapy...
Abstract PURPOSE: To determine whether, in the postoperative setting, accelerated fractionation (AF)...
Background and purpose: Studies on accelerated fractionation (AF) in head and neck cancer have shown...
AbstractIntroductionFractionation plays a pivotal role in determining the effectiveness of radiation...
Introduction: Fractionation plays a pivotal role in determining the effectiveness of radiation and f...
The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) showed that a...
Purpose: To assess the loco regional response and toxicity of patients to concurrent chemo-radiation...
Background Several trials have studied the role of unconventional fractionated radiotherapy in head ...
Background The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) sh...
BACKGROUND: Accelerated radiotherapy delivery has recently been shown to be effective in overcoming ...
BACKGROUND: The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) s...
Item does not contain fulltextBased on the assumption that an accelerated proliferation process prev...
BACKGROUND: The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) s...
Aim: To determine the maximum tolerated dose (MTD) of a short-course accelerated radiotherapy and it...
Purpose: To compare the benefit achieved by concurrent chemoradiotherapy (CRT) and/or accelerated fr...
Purpose: To evaluate the effect of mitomycin C to an accelerated hyperfractionated radiation therapy...
Abstract PURPOSE: To determine whether, in the postoperative setting, accelerated fractionation (AF)...
Background and purpose: Studies on accelerated fractionation (AF) in head and neck cancer have shown...
AbstractIntroductionFractionation plays a pivotal role in determining the effectiveness of radiation...
Introduction: Fractionation plays a pivotal role in determining the effectiveness of radiation and f...
The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) showed that a...
Purpose: To assess the loco regional response and toxicity of patients to concurrent chemo-radiation...
Background Several trials have studied the role of unconventional fractionated radiotherapy in head ...
Background The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) sh...
BACKGROUND: Accelerated radiotherapy delivery has recently been shown to be effective in overcoming ...
BACKGROUND: The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) s...
Item does not contain fulltextBased on the assumption that an accelerated proliferation process prev...
BACKGROUND: The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) s...
Aim: To determine the maximum tolerated dose (MTD) of a short-course accelerated radiotherapy and it...
Purpose: To compare the benefit achieved by concurrent chemoradiotherapy (CRT) and/or accelerated fr...